Unknown

Dataset Information

Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants.


ABSTRACT:

Background

Preterm infants are susceptible to hyperglycaemia and hypoglycaemia, which may lead to adverse neurodevelopment. The use of continuous glucose monitoring (CGM) devices might help in keeping glucose levels in the normal range, and reduce the need for blood sampling. However, the use of CGM might be associated with harms in the preterm infant.

Objectives

To assess the benefits and harms of CGM versus intermittent modalities to measure glycaemia in preterm infants 1. at risk of hypoglycaemia or hyperglycaemia; 2. with proven hypoglycaemia; or 3. with proven hyperglycaemia.

Search methods

We searched CENTRAL (2021, Issue 4); PubMed; Embase; and CINAHL in April 2021. We also searched clinical trials databases, conference proceedings, and reference lists of retri

SUBMITTER: Galderisi A 

PROVIDER: S-EPMC8690212 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature